Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “SLICING”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,441 records · Page 80

SU-D-BRA-05: Toward Understanding the Robustness of Radiomics Features in CT

Purpose: To gauge the impact of inter-scanner variability on radiomics features in computed tomography (CT). Methods: We compared the radiomics features calculated for 17 scans of the specially designed Credence Cartridge Radiomics (CCR) phantom with those calculated for 20 scans of non–small cell lung cancer (NSCLC) tumors. The scans were acquired at four medical centers using General Electric, Philips, Siemens, and Toshiba CT scanners. Each center used its own routine thoracic imaging protocol. To produce a large dynamic range of radiomics feature values, the CCR phantom has 10 cartridges comprising different materials. The features studied were derived from the neighborhood gray-tone difference matrix or image intensity histogram. To quantify the significance of the inter-scanner variability, we introduced the metric “feature noise”, which compares the ratio of inter-scanner variability and inter-patient variability in decibels, positive values indicating substantial noise. We performed hierarchical clustering based to look for dependence of the features on the scan acquisition parameters. Results: For 5 of the 10 features studied, the inter-scanner variability was larger than the inter-patient variability. Of the 10 materials in the phantom, shredded rubber seemed to produce feature values most similar to those of the NSCLC tumors. The feature busyness had the greatest feature noise (14.3 dB), whereas texture strength had the least (−14.6 dB). Hierarchical clustering indicated that the features depended in part on the scanner manufacturer, image slice thickness, and pixel size. Conclusion: The variability in the values of radiomics features calculated for CT images of a radiomics phantom can be substantial relative to the variability in the values of these features calculated for CT images of NSCLC tumors. These inter-scanner differences and their effects should be carefully considered in future radiomics studies.

60 APPLIED LIFE SCIENCES↗

SU-E-E-12: Validation of the Implementation of Different CT Scanners in Proton Treatment Planning

Purpose: To quantify the impact of the relationship of CT number and Relative Stopping Power (RSP) among different CT-scanners in the evaluation of dose distribution, for different tumor sites and proton therapy modalities like Pencil Beam and Uniform Scanning. Methods: The same tissue characterization phantom was used to analyze the difference in the X-rays energy spectra of 2 CT scanners of the same vendor. One CT is for planning and the other for treatment verification. The Hounsfield unit (HU) variations and associated dosimetric uncertainty were investigated in uniform scanning and pencil beam treatment plans of different sites. At the same time comparisons of the CT calibration curve were done using the same acquisition protocols. The phantom was imaged on a 16 multi-row CT scanner, with energies of 120 and 140 kVp,currents of 263 and 245 mA and slice thickness of 2 and 3mm respectively. The dosimetric uncertainty of the plans was evaluated in a homogeneus phantom comparing DVHs, gamma index criteria 3% 3mm, and range between them. Results: The variation of HU was within the standard deviation of the average for each tissue substitute. The curves fitted with a bilinear interpolation show a maximum deviation in high density materials like cortical bone and solid water, where the HU values deviated more than 0,6% for the 120kVp protocol. For the others curves the deviation was more than 2% for low densities materials. The gamma index uncertainty criteria passed in all the cases. Conclusion: The HU variations for the different scanners were ≤3%. Lower than the 3,5% uncertainties considered in our treatment planning system. The dosimetric analysis shows that the X-ray spectrum has a small effect on the HU-RSP curve, allowing the use of a single tissue characterization curve in our proton treatment planning system for plans verifications.

60 APPLIED LIFE SCIENCES↗

SU-E-P-11: Comparison of Image Quality and Radiation Dose Between Different Scanner System in Routine Abdomen CT

Purpose To evaluate image quality and radiation dose of routine abdomen computed tomography exam with the automatic current modulation technique (ATCM) performed in two different brand 64-slice CT scanners in our site. Materials and Methods A retrospective review of routine abdomen CT exam performed with two scanners; scanner A and scanner B in our site. To calculate standard deviation of the portal hepatic level with a region of interest of 12.5 mm x 12.5mm represented to the image noise. The radiation dose was obtained from CT DICOM image information. Using Computed tomography dose index volume (CTDIv) to represented CT radiation dose. The patient data in this study were with normal weight (about 65–75 Kg). Results The standard deviation of Scanner A was smaller than scanner B, the scanner A might with better image quality than scanner B. On the other hand, the radiation dose of scanner A was higher than scanner B(about higher 50–60%) with ATCM. Both of them, the radiation dose was under diagnostic reference level. Conclusion The ATCM systems in modern CT scanners can contribute a significant reduction in radiation dose to the patient. But the reduction by ATCM systems from different CT scanner manufacturers has slightly variation. Whatever CT scanner we use, it is necessary to find the acceptable threshold of image quality with the minimum possible radiation exposure to the patient in agreement with the ALARA principle.

60 APPLIED LIFE SCIENCES↗

SU-E-P-31: Quantifying the Amount of Missing Tissue in a Digital Breast Tomosynthesis

Purpose: To automatically quantify the amount of missing tissue in a digital breast tomosynthesis system using four stair-stepped chest wall missing tissue gauges in the Tomophan™ from the Phantom Laboratory and image processing from Image Owl. Methods: The Tomophan™ phantom incorporates four stair-stepped missing tissue gauges by the chest wall, allowing measurement of missing chest wall in two different locations along the chest wall at two different heights. Each of the four gauges has 12 steps in 0.5 mm increments rising from the chest wall. An image processing algorithm was developed by Image Owl that first finds the two slices containing the steps then finds the signal through the highest step in all four gauges. Using the signal drop at the beginning of each gauge the distance to the end of the image gives the length of the missing tissue gauge in millimeters. Results: The Tomophan™ was imaged in digital breast tomosynthesis (DBT) systems from various vendors resulting in 46 cases used for testing. The results showed that on average 1.9 mm of 6 mm of the gauges are visible. A small focus group was asked to count the number of visible steps for each case which resulted in a good agreement between observer counts and computed data. Conclusion: First, the results indicate that the amount of missing chest wall can differ between vendors. Secondly it was shown that an automated method to estimate the amount of missing chest wall gauges agreed well with observer assessments. This finding indicates that consistency testing may be simplified using the Tomophan™ phantom and analysis by an automated image processing named Tomo QA. In general the reason for missing chest wall may be due to a function of the beam profile at the chest wall as DBT projects through the angular sampling. Research supported by Image Owl, Inc., The Phantom Laboratory, Inc. and Raforninn ehf; Mallozzi and Healy employed by The Phantom Laboratory, Inc.; Goodenough is a consultant to The Phantom Laboratory, Inc.; Fredriksson, Kristbjornsson, Olafsson, Oskarsdottir and Olafsdottir are employed by Raforninn, Ehf.

60 APPLIED LIFE SCIENCES↗

SU-E-P-39: Characterization of Dose Impact On Different Beam Fields Size Attenuation for Elekta IGRT Couch

Purpose: Quantification of the dosimetric impact of the Elekta IGRT treatment couch in different beam field sizes. Established the relationship of relative dose versus beam angle at different beam field sizes. Methods: Measurements of couch attenuation were performed at gantry angles from 180° to 120°, using a 0.125cc semiflex ionization chamber, isocentrically placed in the center of a homogeneous cylindric sliced RW3 phantom for 6 photon beams. Measurements were performed at six different field sizes (3×3, 5×5, 7×7,10×10, 12×12 and 15×15 cm2). The phantom were positioned at the center of the couche,100 MU were delivered at every gantry angle. The dose difference to the ion chamber was determined. Results: For oblique fields with 6 MV photons at the same gantry angle the attenuation coefficient value from the lagest to the smallest the order is field size 7 cm2,5 cm2,10 cm2,12 cm2,15 cm2 and 3 cm2. The biggest couch attenuation by up to 4.15% at the gantry angle of 140°for the field size of 7 cm2, while for the field size of 3 cm2 the couch attenuated value only 3.5%. The other field size couch attenuation values are between the couch attenuated value of field size of 7 cm2 and 3 cm2 Conclusion: The recommended treatment couch attenuation measured beam field size is 10×10 or 12×12 cm2. When measured using the beam field size 3×3 cm2 the tested value will be lower, while measuerd using the beam field size 7×7 cm2 the tested value will be higer than the recommended beam field size. This should be noted when modeling the treatment couch in the treatment planning system.

60 APPLIED LIFE SCIENCES↗

SU-E-I-02: Characterizing Low-Contrast Resolution for Non-Circular CBCT Trajectories

Purpose: The use of non-circular scanning trajectories with optimization-basedreconstruction algorithms can be used in conjunction with non-planaracquisition geometries for axial field-of-view (FOV) extension incone-beam CT (CBCT). To evaluate the utility of these trajectories,quantitative image quality metrics should be evaluated. Low-contrastresolution (LCR) and CT number accuracy are significant challenges forCBCT. With unprecedented axial coverage provided by thesetrajectories, measuring such metrics throughout the axial range iscritical. There are currently no phantoms designed to measurelow-contrast resolution over such an extended volume. Methods: The CATPHAN (The Phantom Laboratory, Salem NY) is the current standardfor image quality evaluation. While providing several useful modulesfor different evaluation metrics, each module was designed to beevaluated in a single slice and not for comparison across axialpositions. To characterize the LCR and HU accuracy over an extendedaxial length, we have designed and built a phantom with evaluationmodules at multiple and adjustable axial positions. Results: The modules were made from a cast polyurethane resin. Holes rangingfrom 1/8 to 5/8 inch were added at a constant radius from the modulecenter into which rods of two different plastic materials were pressedto provide two nominal levels of contrast (1.0% and 0.5%). Largerholes were bored to accept various RMI plugs with known electrondensities for HU accuracy evaluation. The modules can be inserted intoan acrylic tube long enough to cover the entire axial FOV and theirpositions adjusted to desired evaluation points. Conclusion: This phantom allows us to measure the LCR and HU accuracy across theaxial coverage within a single acquisition. These metrics can be usedto characterize the impact different trajectories and reconstructionparameters have on clinically relevant image quality performancemetrics. Funding was provided in part by Varian Medical Systems and NIH R01 Grants Nos. CA158446, CA182264, EB018102, and EB000225. The contents of this poster are solely the responsibility of the authors and do not necessarily represent the official view of any of the supporting organizations.

60 APPLIED LIFE SCIENCES↗

SU-E-I-27: Estimating KERMA Area Product for CT Localizer Images

Purpose: To estimate the free-in-air KERMA-Area Product (KAP) incident on patients due to CT localizer scans for common CT exams. Methods: In-plane beam intensity profiles were measured in localizer acquisition mode using OSLs for a 64 slice MDCT scanner (Lightspeed VCT, GE Medical Systems, Waukesha WI). The z-axis beam width was measured as a function of distance from isocenter. The beam profile and width were used to calculate a weighted average air KERMA per unit mAs as a function of intercepted x-axis beam width for objects symmetric about the localizer centerline.Patient areas were measured using manually drawn regions and divided by localizer length to determine average width. Data were collected for 50 head exams (lateral localizer only), 15 head/neck exams, 50 chest exams, and 50 abdomen/pelvis exams. Mean patient widths and acquisition techniques were used to calculate the weighted average free-in-air KERMA, which was multiplied by the patient area to estimate KAP. Results: Scan technique was 120 kV tube voltage, 10 mA current, and table speed of 10 cm/s. The mean ± standard deviation values of KAP were 120 ± 11.6, 469 ± 62.6, 518 ± 45, and 763 ± 93 mGycm{sup 2} for head, head/neck, chest, and abdomen/pelvis exams, respectively. For studies with AP and lateral localizers, the AP/lateral area ratio was 1.20, 1.33, and 1.24 for the head/neck, chest, and abdomen/pelvis exams, respectively. However, the AP/lateral KAP ratios were 1.12, 1.08, and 1.07, respectively. Conclusion: Calculation of KAP in CT localizers is complicated by the non-uniform intensity profile and z-axis beam width. KAP values are similar to those for simple radiographic exams such as a chest radiograph and represent a small fraction of the x-ray exposure at CT. However, as CT doses are reduced the localizer contribution will be a more significant fraction of the total exposure.

60 APPLIED LIFE SCIENCES↗

SU-E-I-28: Introduction and Investigation of Effective Diameter Ratios as a New Patient Size Metric for Use in CT

Purpose: To introduce and investigate effective diameter ratios as a new patient metric for use in computed tomography protocol selection as a supplement to patient-specific size parameter data. Methods: The metrics of outer effective diameter and inner effective diameter were measured for 7 post-mortem subjects scanned with a standardized chest/abdomen/pelvis (CAP) protocol on a 320-slice MDCT scanner. The outer effective diameter was calculated by obtaining the anterior/posterior and lateral dimensions of the imaged anatomy at the middle of the scan range using Effective Diameter= SQRT(AP height*Lat Width). The inner effective diameter was calculated with the same equation using the AP and Lat dimensions of the anatomy excluding the adipose tissue. The ratio of outer to inner effective diameter was calculated for each subject. A relationship to BMI, weight, and CTDI conversion coefficients was investigated. Results: For the largest subject with BMI of 43.85 kg/m2 and weight of 255 lbs the diameter ratio was calculated as 1.33. For the second largest subject with BMI of 33.5 kg/m2 and weight of 192.4 lbs the diameter ratio was measured as 1.43, indicating a larger percentage of adipose tissue in the second largest subject’s anatomical composition. For the smallest subject at BMI of 17.4 kg/m2 and weight of 86 lbs a similar tissue composition was indicated as a subject with BMI of 24.2 kg/m2 and weight of 136 lbs as they had the same diameter ratios of 1.11. Conclusion: The diameter ratio proves to contain information about anatomical composition that the BMI and weight alone do not. The utility of this metric is still being examined but could prove useful for determining MDCT techniques and for giving a more in depth detail of the composition of a patient’s body habitus.

60 APPLIED LIFE SCIENCES↗

SU-E-I-33: Establishment of CT Diagnostic Reference Levels in Province Nova Scotia

Purpose: To evaluate patient radiation dose from the most frequently performed CT examinations and to establish provincial diagnostic reference levels (DRLs) as a tool for protocol optimization. Methods: The study investigated the following CT examinations: head, chest, abdomen/pelvis, and chest/abdomen/pelvis (CAP). Dose data, volume CT dose index (CTDIvol) and dose-length product (DLP), were collected from 15 CT scanners installed during 2004–2014 in 11 hospital sites of Nova Scotia. All scanners had dose modulation options and multislice capability (16–128 detector rows). The sample for each protocol included 15 average size patients (70±20 kg). Provincial DRLs were calculated as the 75th percentile of patient dose distributions. The differences in dose between hospitals were evaluated with a single factor ANOVA statistical test. Generalized linear modeling was used to determine the factors associated with higher radiation dose. A sample of 36 abdominal studies performed on three different scanners was blinded and randomized for an assessment by an experienced radiologist who graded the imaging quality of anatomic structures. Results: Data for 900 patients were collected. The DRLs were proposed using CTDIvol (mGy) and DLP (mGy*cm) values for CT head (67 and 1049, respectively), chest (12 and 393), abdomen/pelvis (16 and 717), and CAP (14 and 1034). These DRLs were lower than the published national data except for the head CTDIvol. The differences between the means of the dose distributions from each scanner were statistically significant (p<0.05) for all examinations. A very weak correlation was found between the dose and the scanner age or the number of slices with Pearson’s correlation coefficients of 0.011–0.315. The blinded analysis of image quality demonstrated no clinically significant difference except for the noise category. Conclusion: Provincial DRLs were established for typical CT examinations. The variations in dose between the hospitals suggested a large potential for optimization of examinations. Radiology Research Foundation grant.

60 APPLIED LIFE SCIENCES↗

SU-E-I-65: Estimation of Tagging Efficiency in Pseudo-Continuous Arterial Spin Labeling (pCASL) MRI

Purpose: pCASL was recommended as a potent approach for absolute cerebral blood flow (CBF) quantification in clinical practice. However, uncertainties of tagging efficiency in pCASL remain an issue. This study aimed to estimate tagging efficiency by using short quantitative pulsed ASL scan (FAIR-QUIPSSII) and compare resultant CBF values with those calibrated by using 2D Phase Contrast (PC) MRI. Methods: Fourteen normal volunteers participated in this study. All images, including whole brain (WB) pCASL, WB FAIR-QUIPSSII and single-slice 2D PC, were collected on a 3T clinical MRI scanner with a 8-channel head coil. DeltaM map was calculated by averaging the subtraction of tag/control pairs in pCASL and FAIR-QUIPSSII images and used for CBF calculation. Tagging efficiency was then calculated by the ratio of mean gray matter CBF obtained from pCASL and FAIR-QUIPSSII. For comparison, tagging efficiency was also estimated with 2D PC, a previously established method, by contrast WB CBF in pCASL and 2D PC. Feasibility of estimation from a short FAIR-QUIPSSII scan was evaluated by number of averages required for obtaining a stable deltaM value. Setting deltaM calculated by maximum number of averaging (50 pairs) as reference, stable results were defined within ±10% variation. Results: Tagging efficiencies obtained by 2D PC MRI (0.732±0.092) were significantly lower than which obtained by FAIRQUIPPSSII (0.846±0.097) (P<0.05). Feasibility results revealed that four pairs of images in FAIR-QUIPPSSII scan were sufficient to obtain a robust calibration of less than 10% differences from using 50 pairs. Conclusion: This study found that reliable estimation of tagging efficiency could be obtained by a few pairs of FAIR-QUIPSSII images, which suggested that calibration scan in a short duration (within 30s) was feasible. Considering recent reports concerning variability of PC MRI-based calibration, this study proposed an effective alternative for CBF quantification with pCASL.

60 APPLIED LIFE SCIENCES↗

SU-E-J-04: Integration of Interstitial High Intensity Therapeutic Ultrasound Applicators On a Clinical MRI-Guided High Intensity Focused Ultrasound Treatment Planning Software Platform

Purpose: Interstitial high intensity therapeutic ultrasound (HITU) applicators can be used to ablate tissue percutaneously, allowing for minimally-invasive treatment without ionizing radiation [1,2]. The purpose of this study was to evaluate the feasibility and usability of combining multielement interstitial HITU applicators with a clinical magnetic resonance imaging (MRI)-guided focused ultrasound software platform. Methods: The Sonalleve software platform (Philips Healthcare, Vantaa, Finland) combines anatomical MRI for target selection and multi-planar MRI thermometry to provide real-time temperature information. The MRI-compatible interstitial US applicators (Acoustic MedSystems, Savoy, IL, USA) had 1–4 cylindrical US elements, each 1 cm long with either 180° or 360° of active surface. Each applicator (4 Fr diameter, enclosed within a 13 Fr flexible catheter) was inserted into a tissue-mimicking agar-silica phantom. Degassed water was circulated around the transducers for cooling and coupling. Based on the location of the applicator, a virtual transducer overlay was added to the software to assist targeting and to allow automatic thermometry slice placement. The phantom was sonicated at 7 MHz for 5 minutes with 6–8 W of acoustic power for each element. MR thermometry data were collected during and after sonication. Results: Preliminary testing indicated that the applicator location could be identified in the planning images and the transducer locations predicted within 1 mm accuracy using the overlay. Ablation zones (thermal dose ≥ 240 CEM43) for 2 active, adjacent US elements ranged from 18 mm × 24 mm (width × length) to 25 mm × 25 mm for the 6 W and 8 W sonications, respectively. Conclusion: The combination of interstitial HITU applicators and this software platform holds promise for novel approaches in minimally-invasive MRI-guided therapy, especially when bony structures or air-filled cavities may preclude extracorporeal HIFU.[1] Diederich et al. IEEE UFFFC 46.5 (1999): 1218.[2] Chopra et al. PMB 50.21 (2005): 4957. Funding support was provided by Philips Healthcare and in-kind support from Acoustic MedSystems Inc. Ari Partanen is a paid employee of Philips Healthcare. Goutam Ghoshal and Everette Clif Burdette are paid employees of Acoustic MedSystems Inc.

60 APPLIED LIFE SCIENCES↗

SU-E-J-110: Dosimetric Analysis of Respiratory Motion Based On Four-Dimensional Dose Accumulation in Liver Stereotactic Body Radiotherapy

Purpose: Respiratory motion in thoracic and abdominal region could lead to significant underdosing of target and increased dose to healthy tissues. The aim of this study is to evaluate the dosimetric effect of respiratory motion in conventional 3D dose by comparing 4D deformable dose in liver stereotactic body radiotherapy (SBRT). Methods: Five patients who had previously treated liver SBRT were included in this study. Four-dimensional computed tomography (4DCT) images with 10 phases for all patients were acquired on multi-slice CT scanner (Siemens, Somatom definition). Conventional 3D planning was performed using the average intensity projection (AIP) images. 4D dose accumulation was calculated by summation of dose distribution for all phase images of 4DCT using deformable image registration (DIR) . The target volume and normal organs dose were evaluated with the 4D dose and compared with those from 3D dose. And also, Index of achievement (IOA) which assesses the consistency between planned dose and prescription dose was used to compare target dose distribution between 3D and 4D dose. Results: Although the 3D dose calculation considered the moving target coverage, significant differences of various dosimetric parameters between 4D and 3D dose were observed in normal organs and PTV. The conventional 3D dose overestimated dose to PTV, however, there was no significant difference for GTV. The average difference of IOA which become ‘1’ in an ideal case was 3.2% in PTV. The average difference of liver and duodenum was 5% and 16% respectively. Conclusion: 4D dose accumulation which can provide dosimetric effect of respiratory motion has a possibility to predict the more accurate delivered dose to target and normal organs and improve treatment accuracy. This work was supported by the Radiation Technology R&D program (No. 2013M2A2A7043498) and the Mid-career Researcher Program (2014R1A2A1A10050270) through the National Research Foundation of Korea funded by the Ministry of Science, ICT&Future Planning (MSIP) of Korea.

60 APPLIED LIFE SCIENCES↗

SU-E-J-214: MR Protocol Development to Visualize Sirius MRI Markers in Prostate Brachytherapy Patients for MR-Based Post-Implant Dosimetry

Purpose: The current CT-based post-implant dosimetry allows precise seed localization but limited anatomical delineation. Switching to MR-based post-implant dosimetry is confounded by imprecise seed localization. One approach is to place positive-contrast markers (Sirius) adjacent to the negative-contrast seeds. This patient study aims to assess the utility of a 3D fast spoiled gradient-recalled echo (FSPGR) sequence to visualize Sirius markers for post-implant dosimetry. Methods: MRI images were acquired in prostate implant patients (n=10) on Day 0 (day-of-implant) and Day 30. The post-implant MR protocol consisted of 3D T2-weighted fast-spin-echo (FSE), T2-weighted 2D-FSE (axial) and T1-weighted 2D-FSE (axial/sagittal/coronal). We incorporated a 3D-FSPGR sequence into the post-implant MR protocol to visualize the Sirius markers. Patients were scanned with different number-of-excitations (6, 8, 10), field-of-view (10cm, 14cm, 18cm), slice thickness (1mm, 0.8mm), flip angle (14 degrees, 20 degrees), bandwidth (122.070 Hz/pixel, 325.508 Hz/pixel, 390.625 Hz/pixel), phase encoding steps (160, 192, 224, 256), frequency-encoding direction (right/left, anterior/posterior), echo-time type (minimum-full, out-of-phase), field strength (1.5T, 3T), contrast (with, without), scanner vendor (Siemens, GE), coil (endorectal-coil only, endorectal-and-torso-coil, torsocoil only), endorectal-coil filling (30cc, 50cc) and endorectal-coil filling type (air, perfluorocarbon [PFC]). For post-implant dosimetric evaluation with greater anatomical detail, 3D-FSE images were fused with 3D-FSPGR images. For comparison with CT-based post-implant dosimetry, CT images were fused with 3D-FSPGR images. Results: The 3D-FSPGR sequence facilitated visualization of markers in patients. Marker visualization helped distinguish signal voids as seeds versus needle tracks for more definitive MR-based post-implant dosimetry. On the CT-MR fused images, the distance between the seed on CT to MR images was 3.2±1.6mm in patients with no endorectal coil, 2.3±0.8mm in patients with 30cc-PFC-filled endorectal-coil and 5.0±1.8mm in patients with 50cc-PFC-filled endorectal-coil. Conclusion: An MR protocol to visualize positive-contrast Sirius markers to assist in the identification of negative-contrast seeds was demonstrated. S Frank is a co-founder of C4 Imaging LLC, the manufacturer of the MRI markers.

60 APPLIED LIFE SCIENCES↗

SU-E-J-215: Towards MR-Only Image Guided Identification of Calcifications and Brachytherapy Seeds: Application to Prostate and Breast LDR Implant Dosimetry

Purpose: To identify and analyze the appearance of calcifications and brachytherapy seeds on magnitude and phase MRI images and to investigate whether they can be distinguished from each other on corrected phase images for application to prostate and breast low dose rate (LDR) implant dosimetry. Methods: An agar-based gel phantom containing two LDR brachytherapy seeds (Advantage Pd-103, IsoAid, 0.8mm diameter, 4.5mm length) and two spherical calcifications (large: 7mm diameter and small: 4mm diameter) was constructed and imaged on a 3T Philips MR scanner using a 16-channel head coil and a susceptibility weighted imaging (SWI) sequence (2mm slices, 320mm FOV, TR/ TE= 26.5/5.3ms, 15 degree flip angle). The phase images were unwrapped and corrected using a 32×32, 2D Hanning high pass filter to remove background phase noise. Appearance of the seeds and calcifications was assessed visually and quantitatively using Osirix (http://www.osirix-viewer.com/). Results: As expected, calcifications and brachytherapy seeds appeared dark (hypointense) relative to the surrounding gel on the magnitude MRI images. The diameter of each seed without the surrounding artifact was measured to be 0.1 cm on the magnitude image, while diameters of 0.79 and 0.37 cm were measured for the larger and smaller calcifications, respectively. On the corrected phase images, the brachytherapy seeds and the calcifications appeared bright (hyperintense). The diameter of the seeds was larger on the phase images (0.17 cm) likely due to the dipole effect. Conclusion: MRI has the best soft tissue contrast for accurate organ delineation leading to most accurate implant dosimetry. This work demonstrated that phase images can potentially be useful in identifying brachytherapy seeds and calcifications in the prostate and breast due to their bright appearance, which helps in their visualization and quantification for accurate dosimetry using MR-only. Future work includes optimizing phase filters to best identify and delineate seeds and calcifications.

60 APPLIED LIFE SCIENCES↗

SU-E-J-225: CEST Imaging in Head and Neck Cancer Patients

Purpose: Chemical Exchange Saturation Transfer (CEST) imaging is an MRI technique enables the detection and imaging of metabolically active compounds in vivo. It has been used to differentiate tumor types and metabolic characteristics. Unlike PET/CT,CEST imaging does not use isotopes so it can be used on patient repeatedly. This study is to report the preliminary results of CEST imaging in Head and Neck cancer (HNC) patients. Methods: A CEST imaging sequence and the post-processing software was developed on a 3T clinical MRI scanner. Ten patients with Human papilloma virus positive oropharyngeal cancer were imaged in their immobilized treatment position. A 5 mm slice CEST image was acquired (128×128, FOV=20∼24cm) to encompass the maximum dimension of tumor. Twenty-nine off-set frequencies (from −7.8ppm to +7.8 ppm) were acquired to obtain the Z-spectrum. Asymmetry analysis was used to extract the CEST contrasts. ROI at the tumor, node and surrounding tissues were measured. Results: CEST images were successfully acquired and Zspectrum asymmetry analysis demonstrated clear CEST contrasts in tumor as well as the surrounding tissues. 3∼5% CEST contrast in the range of 1 to 4 ppm was noted in tumor as well as grossly involved nodes. Injection of glucose produced a marked increase of CEST contrast in tumor region (∼10%). Motion and pulsation artifacts tend to smear the CEST contrast, making the interpretation of the image contrast difficult. Field nonuniformity, pulsation in blood vesicle and susceptibility artifacts caused by air cavities were also problematic for CEST imaging. Conclusion: We have demonstrated successful CEST acquisition and Z-spectrum reconstruction on HNC patients with a clinical scanner. MRI acquisition in immobilized treatment position is critical for image quality as well as the success of CEST image acquisition. CEST images provide novel contrast of metabolites in HNC and present great potential in the pre- and post-treatment assessment of patients undergoing radiation therapy.

60 APPLIED LIFE SCIENCES↗

SU-E-J-269: Tracking of Tumor Regression for Stage III Lung Cancer Using CBCT

Purpose: This study is to evaluate the tumor regression over the course of EBRT treatment and to determine the difference of tumor reduction for stage III lung squamous cell cancer (SCC) and adenocarcinoma using CBCT. Methods: Twenty three stage III lung cancer patients treated in our clinic who had daily cone beam CT (CBCT) were selected for this study (16 adenocarcinoma and 7 SCC cases). Patients received prescription dose in the range of 50Gy–71.4Gy (mean =60.3Gy, median =50Gy) at 1.8Gy or 2Gy per fraction. Treatments spanned over a minimum of five weeks. Initial mean volume of the gross tumor volume (GTV) was 123cc (range = 14.7cc–353.3cc). For this study, we choose six sets of CBCTs at an interval of one week, starting from the first fraction of treatment. Daily CBCTs from treatment linac computer were transferred to MIM Software version 6.0. An experienced physician contoured the primary GTV on each slices of the CBCT for these patients. Results: A consistent regression of the GTVs was observed in all patients, except in one patient (adeno case) where GTV did not change. Weekly volumetric reduction was in the range of 11.2%–16.6%. Maximum reductions were noticed in the first two weeks of the treatment cycle; mean overall (for adeno+SCC) reductions were 16.6%, 14.2% in week-1 and week-2, respectively. Mean reduction over five weeks of treatment was 49.8% (range = 0.1%–75.5%). Higher reduction was observed in SCC patients as compare to adenocarcinoma cases (54.9% vs. 47.6%); however, the difference was not statistically significant (p-value > 0.05). Conclusion: Large regression of tumors over the course of EBRT for stage III lung cancer patients was observed. Both SCC and adenocarcinoma responded well; overall reduction for SCC cases was higher. A future study is warranted for determining the co-relation between tumor volume reduction and treatment outcome.

60 APPLIED LIFE SCIENCES↗

SU-E-T-12: A Comparative Dosimetric Study of Pre and Post Prostate Iodine-125 Permanent Seed Implants

Purpose: Post-implant dosimetry has become the gold standard for prostate implant evaluation. The goal of this research is to compare the dosimetry between pre-plan and post-plan in permanent prostate seed implant brachytherapy. Methods: A retrospective study of 91 patients treated with Iodine-125 prostate seed implant between year 2012∼2014 were performed. All plans were created using a VariSeed 8.0 planning system. Pre-plan ultrasound images were acquired using 0.5 cm slice thickness. Post-plan CT images acquired about 1–4 weeks after implant, fused with the preplan ultrasound images. The prostate and urethra contours were generated using the fusion of ultrasound and CT images. Iodine-125 seed source activities varied between 0.382 to 0.414 mCi per seed. The loading patterns varied slightly between patients depending on the prostate size. Statistical analysis of pre and post plans for prostate and urethra volumes, V100%, V150% and D90, and urethra D10 were performed and reported. Results: The pre and post implant average prostate size was 36.90cc vs. 38.58cc; V100% was 98.33% vs. 96.89%; V150% was 47.09% vs. 56.95%; D90 was 116.35Gy vs. 116.12Gy, urethra volume was 1.72cc vs. 1.85cc, urethra D10% was 122.0% vs. 135.35%, respectively. There was no statistically significant difference between the pre and post-plan values for D90(p-value=0.43). However, there are significant differences between other parameters most likely due to post surgical edema; prostate size (p-value= 0.00015); V100% (p-value=3.7803E-07); V150% (p-value=1.49E-09); urethra volume (p-value= 2.77E-06); Urethra D10 (p-value=7.37E-11). Conclusion: The post-plan dosimetry using CT image set showed similar D90 dose coverage to the pre-plan using the ultrasound image dataset. The study showed that our prostate seed implants have consistently delivered adequate therapeutic dose to the prostate while sparing urethra. Future studies to correlate dose versus biochemical response using patients’ PSA values as well as patients’ survival are warranted.

60 APPLIED LIFE SCIENCES↗

SU-E-T-63: A Preliminary Study of Gold Nanoparticles Enhanced Cone Beam Computed Tomography

Purpose: Gold nanoparticles (GNPs) have potential of being used as a new-generation contrast agent to enhance CT imaging of cancer. This feasibility study is to determine the GNP concentration required to provide sufficient image contrast in small animal cone beam CT (CBCT) imaging. Methods: The GNPs used are nanorods with 10nm diameter and 44nm length. A 50µl GNP colloid with an original GNP concentration of 3.6mg/ml was diluted to five different concentrations at 2.4, 2.1, 2.0, 1.9 and 1.8mg/ml, respectively. The GNP colloid was enclosed in a 150µl vial, and the GNP colloid vial was submerged in a water bottle for CBCT. CBCTs were acquired with x-ray energy of 65kVp and tube current of 1.5mA. In addition, to evaluate the optimal x-ray energy for GNP detection in CBCT, the GNP colloid of 1.8mg/ml was also imaged at x-ray energy of 45kVp and 85kVp. Regions of interest were placed in axial CBCT slices contouring the GNP colloid volume and a same volume in the surrounding water to calculate the signal and contrast. Results: For the GNP colloid at concentrations of 3.6, 2.4, 2.1, 2.0, 1.9 and 1.8mg/ml, the image contrasts between GNP colloid and water were 68±4, 33±4, 23±3, 20±3, 13±4, and 10±3 HU, respectively. At 1.8mg/ml concentration level, the image contrasts were 16±3 and 7±4 HU, respectively, when the x-ray energy was set at 45kVp and 85kVp. Conclusion: The minimal GNP concentration required on our small animal CBCT was estimated to be around 1.8mg/ml due to the fact that the minimum image contrast for adequate differentiation in CT is about 8 HU. CBCT at lower x-ray energy, i.e. 45kVp, can provide better image contrast than at higher energies, i.e., 65kVp and 85kVp. A study of GNP enhanced CBCT for in vivo small animal imaging is ongoing efforts in our group.

60 APPLIED LIFE SCIENCES↗